After the approval
- Published: January 30, 2020
- Last updated: January 30, 2020
An approved pharmaceutical product is followed throughout its life cycle. For example, by regularly submitting safety reports or updating a risk management plan annually to monitor safety and minimize existing risks.
It is a matter of the person who holds the marketing authorization is obliged to keep the pharmaceutical product up to date, and if necessary apply for or report changes. But also for example, for some pharmaceutical products, there are requirements for educational materials to minimize risks, among other things.